BioNexus Gene Lab
BGLC
$0.42
Share price
-3.48%
Change (1 day)
46.48%
Change (1 year)
Categories
BioNexus Gene Lab (BGLC) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $1.81 M
According to BioNexus Gene Lab's latest financial reports the company's total liabilities are $1.81 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
BioNexus Gene Lab - Total liabilities on balance sheet (from 2019 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $2.07 M | -13.34% |
| 2021-12-31 | $2.39 M | -30.65% |
| 2020-12-31 | $3.45 M | 3071.74% |
| 2019-12-31 | $0.1 M | -16.45% |
| 2018-12-31 | $0.13 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $22.14 M | 1,118.35% | 🇺🇸 USA |